Description

Send us a message with this link, we would love to hear from you. Standard message rates may apply.

Respiratory syncytial virus (RSV) is a common respiratory virus that can be dangerous for infants. This episode of Your Checkup provides essential information about RSV, exploring new prevention methods like the monoclonal antibody nirsevimab and the maternal RSV vaccine. We discuss how they work, who should consider them, and their safety profiles. Tune in to learn how to safeguard your baby from this potentially serious virus.

Takeaways

• RSV is a common respiratory virus that can severely affect infants.
• Nersivimab is a new immunization option for RSV prevention.
• The immunization is effective in reducing hospitalizations by 80-90%.
• Maternal antibodies can provide temporary immunity to infants.
• The BreezVow vaccine is recommended for pregnant individuals to protect infants.
• RSV season typically runs from September to March.
• Parents should consult healthcare providers about RSV immunization options.
• The conversation highlights the importance of patient education in healthcare.

Keywords

RSV, immunization, healthcare, pediatric care, respiratory virus, vaccines, maternal antibodies, health education, patient care, family medicine

Support the show

Subscribe to Our Newsletter!

Production and Content: Edward Delesky, MD & Nicole Aruffo, RN
Artwork: Olivia Pawlowski